Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03270241 · ClinicalTrials.gov registry record · NA
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
A NA study of Vitiligo and Dermatology/Skin - Other, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03270241 is a NA study of Vitiligo and Dermatology/Skin - Other that has completed, run by Johns Hopkins University. The registered enrollment target is 10 participants, below the 1,124-participant average among 15 other Vitiligo trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03270241, a NA study of Vitiligo and Dermatology/Skin - Other, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitiligo is a chronic acquired cutaneous disease of pigmentation that affects patients' quality of life across all degrees of involvement and severity. Phototherapy, such as Narrow band UVB (NB-UVB), is a clinically indicated treatment for skin lesions. NB-UVB treatment has been shown to promote repigmentation and normalize cellular behaviors. The investigators would like to analyze the change in protein expression and histological change in skin from NB-UVB treatment in participants with Vitiligo. The investigators are recruiting participants with Vitiligo on the body, arms, and/or legs.
Conditions Studied
Interventions
- DEVICE Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet
Study Locations (1)
Maryland
- Johns Hopkins Outpatient Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2023-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03270241
The ClinicalTrials.gov registry entry for NCT03270241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,124-participant average among 15 other Vitiligo trials with a reported enrollment target (99% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Vitiligo appearing as the primary indexed condition, and to 1 intervention - of which Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet is the first listed.
NCT03270241 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03270241 about?
NCT03270241 is a clinical study titled "Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy". Vitiligo is a chronic acquired cutaneous disease of pigmentation that affects patients' quality of life across all degrees of involvement and severity. Phototherapy, such as Narrow band UVB (NB-UVB), is a clinically indicated treatment for skin lesions. NB-UVB treatment has been shown to promote rep...
What is the current status of trial NCT03270241?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-10-01. Estimated completion is 2023-03-14.
What conditions does trial NCT03270241 study?
This clinical trial studies the following conditions: Vitiligo, Dermatology/Skin - Other.
What interventions are being tested in trial NCT03270241?
The interventions under investigation include: Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet (DEVICE).
Who is sponsoring clinical trial NCT03270241?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03270241 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitiligo
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Photocil (Topical) for the Treatment of Vitiligo
COMPLETED · NA
-
Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells
COMPLETED · NA
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
RECRUITING · Phase 3
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
RECRUITING
-
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.